{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T11:24:22Z","timestamp":1770549862735,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum D\u00fcsseldorf. Anstalt \u00f6ffentlichen Rechts"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To assess the efficacy, safety, and stability of refractive outcomes in hyperopic Laser-Assisted in Situ Keratomileusis (LASIK) with and without the application of Mitomycin C (MMC). This randomized, parallel group, controlled multicenter trial included 140 hyperopic eyes. The participants were randomly assigned to two groups: one receiving LASIK with mitomycin C (MMC) (<jats:italic>n<\/jats:italic>\u2009=\u200970) and the other receiving LASIK without MMC (<jats:italic>n<\/jats:italic>\u2009=\u200970). The primary outcome measures were uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), and safety parameters at six months postoperatively. The statistical analysis employed t-tests, Mann-Whitney tests, and Fisher\u2019s Exact Test, with a significance level of <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05. All 140 eyes (70 per group) were analyzed. No statistically significant differences were identified between the two groups in postoperative UDVA, CDVA, or safety parameters (<jats:italic>p<\/jats:italic>\u2009&gt;\u20090.05). Both groups demonstrated highly effective and safe refractive outcomes. No intraoperative complications or postoperative adverse events were observed. Age and preoperative spherical equivalent did not significantly affect outcomes. Hyperopic LASIK with and without MMC showed comparable efficacy, safety, and stability of refractive outcomes at the six-month postoperative interval. Although MMC use in hyperopic LASIK appears to be a safe procedure, it was not found to be significantly superior to conventional LASIK. Further investigation with longer follow-up periods and larger cohorts is necessary to confirm these results.<\/jats:p>","DOI":"10.1038\/s41598-024-83757-x","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T13:24:01Z","timestamp":1736169841000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Stability of refractive outcomes after hyperopic LASIK with and without Mitomycin C application: a randomized controlled trial"],"prefix":"10.1038","volume":"15","author":[{"given":"Amr","family":"Saad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Frings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,6]]},"reference":[{"key":"83757_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ajo.2017.03.013","volume":"178","author":"D Wen","year":"2017","unstructured":"Wen, D. et al. Postoperative efficacy, predictability, Safety, and visual quality of laser corneal refractive surgery: a Network Meta-analysis. Am. J. Ophthalmol. 178, 65\u201378. https:\/\/doi.org\/10.1016\/j.ajo.2017.03.013 (2017).","journal-title":"Am. J. Ophthalmol."},{"key":"83757_CR2","doi-asserted-by":"publisher","DOI":"10.1097\/j.jcrs.0000000000001153","author":"D Ali\u00f3","year":"2023","unstructured":"Ali\u00f3, D. et al. Femtosecond Laser-assisted in situ Keratomileusis for the treatment of moderate to high hyperopia. J. Cataract Refract. Surg. https:\/\/doi.org\/10.1097\/j.jcrs.0000000000001153 (2023).","journal-title":"J. Cataract Refract. Surg."},{"key":"83757_CR3","first-page":"1","volume":"7","author":"M Moshirfar","year":"2018","unstructured":"Moshirfar, M. et al. Mechanisms of Optical Regression following corneal laser refractive surgery: epithelial and stromal responses. Med. Hypothesis Discov Innov. Ophthalmol. 7, 1\u20139 (2018).","journal-title":"Med. Hypothesis Discov Innov. Ophthalmol."},{"key":"83757_CR4","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1136\/bjophthalmol-2017-311694","volume":"103","author":"BJ Kaluzny","year":"2019","unstructured":"Kaluzny, B. J. et al. Three-year outcomes after high hyperopia correction using photorefractive keratectomy with a large ablation zone. Br. J. Ophthalmol. 103, 849\u2013854. https:\/\/doi.org\/10.1136\/bjophthalmol-2017-311694 (2019).","journal-title":"Br. J. Ophthalmol."},{"key":"83757_CR5","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1097\/ico.0000000000002011","volume":"38","author":"L Gauthier-Fournet","year":"2019","unstructured":"Gauthier-Fournet, L., Penin, F. & Arba Mosquera, S. Six-Month outcomes after high hyperopia correction using laser-assisted in situ keratomileusis with a large ablation zone. Cornea 38, 1147\u20131153. https:\/\/doi.org\/10.1097\/ico.0000000000002011 (2019).","journal-title":"Cornea"},{"key":"83757_CR6","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3928\/1081-597X-20060601-08","volume":"22","author":"MV Netto","year":"2006","unstructured":"Netto, M. V. et al. Effect of prophylactic and therapeutic mitomycin C on corneal apoptosis, Cellular Proliferation, Haze, and long-term keratocyte density in rabbits. J. Refract. Surg. 22, 562\u2013574. https:\/\/doi.org\/10.3928\/1081-597X-20060601-08 (2006).","journal-title":"J. Refract. Surg."},{"key":"83757_CR7","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1001\/archopht.1991.01080080101040","volume":"109","author":"JH Talamo","year":"1991","unstructured":"Talamo, J. H. et al. Modulation of corneal wound healing after excimer laser keratomileusis using topical mitomycin C and steroids. Arch. Ophthalmol. 109, 1141\u20131146. https:\/\/doi.org\/10.1001\/archopht.1991.01080080101040 (1991).","journal-title":"Arch. Ophthalmol."},{"key":"83757_CR8","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.ajo.2006.04.029","volume":"142","author":"AJ Morales","year":"2006","unstructured":"Morales, A. J. et al. Intraoperative mitomycin and corneal endothelium after photorefractive keratectomy. Am. J. Ophthalmol. 142, 400\u2013404. https:\/\/doi.org\/10.1016\/j.ajo.2006.04.029 (2006).","journal-title":"Am. J. Ophthalmol."},{"key":"83757_CR9","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.jcrs.2008.03.007","volume":"34","author":"N Nassiri","year":"2008","unstructured":"Nassiri, N., Farahangiz, S., Rahnavardi, M., Rahmani, L. & Nassiri, N. Corneal endothelial cell injury induced by mitomycin-C in photorefractive keratectomy: nonrandomized controlled trial. J. Cataract Refract. Surg. 34, 902\u2013908. https:\/\/doi.org\/10.1016\/j.jcrs.2008.03.007 (2008).","journal-title":"J. Cataract Refract. Surg."},{"key":"83757_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/ICO.0b013e31821e429d","volume":"31","author":"MR Santhiago","year":"2012","unstructured":"Santhiago, M. R., Netto, M. V., Wilson, S. E. & Mitomycin, C. Biological effects and use in refractive surgery. Cornea 31, 311\u2013321. https:\/\/doi.org\/10.1097\/ICO.0b013e31821e429d (2012).","journal-title":"Cornea"},{"key":"83757_CR11","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.jfo.2021.05.006","volume":"44","author":"S Charpentier","year":"2021","unstructured":"Charpentier, S. et al. Corneal haze post photorefractive keratectomy. J. Fr. Ophtalmol. 44, 1425\u20131438. https:\/\/doi.org\/10.1016\/j.jfo.2021.05.006 (2021).","journal-title":"J. Fr. Ophtalmol."},{"key":"83757_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3928\/1081597x-20090115-03","volume":"25","author":"A Shalaby","year":"2009","unstructured":"Shalaby, A., Kaye, G. B. & Gimbel, H. V. Mitomycin C in photorefractive keratectomy. J. Refract. Surg. 25, 93\u201397. https:\/\/doi.org\/10.3928\/1081597x-20090115-03 (2009).","journal-title":"J. Refract. Surg."},{"key":"83757_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12886-019-1100-7","volume":"19","author":"EM Moawad","year":"2019","unstructured":"Moawad, E. M., Abd Elghany, A. A., Gab-Alla, A. A., Elbassiouny, O. M. & Badawy, M. LASIK-induced corneal changes after correction of hyperopia with and without application of Mitomycin-C. BMC Ophthalmol. 19, 93. https:\/\/doi.org\/10.1186\/s12886-019-1100-7 (2019).","journal-title":"BMC Ophthalmol."},{"key":"83757_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3928\/1081597x-20171116-01","volume":"34","author":"M Garcia-Gonzalez","year":"2018","unstructured":"Garcia-Gonzalez, M., Iglesias-Iglesias, M., Rodriguez-Casanova, D., Gros-Otero, P., Teus, M. A. & J. & Femtosecond Laser-assisted LASIK with and without the adjuvant use of mitomycin C to correct hyperopia. J. Refract. Surg. 34, 23\u201328. https:\/\/doi.org\/10.3928\/1081597x-20171116-01 (2018).","journal-title":"J. Refract. Surg."},{"key":"83757_CR15","doi-asserted-by":"publisher","first-page":"654","DOI":"10.3928\/1081597x-20140903-01","volume":"30","author":"DZ Reinstein","year":"2014","unstructured":"Reinstein, D. Z., Archer, T. J. & Randleman, J. B. JRS standard for reporting astigmatism outcomes of refractive surgery. J. Refract. Surg. 30, 654\u2013659. https:\/\/doi.org\/10.3928\/1081597x-20140903-01 (2014).","journal-title":"J. Refract. Surg."},{"key":"83757_CR16","doi-asserted-by":"publisher","first-page":"4392","DOI":"10.1038\/s41598-021-83881-y","volume":"11","author":"R Shetty","year":"2021","unstructured":"Shetty, R. et al. Safety and efficacy of combination of suberoylamilide hydroxyamic acid and mitomycin C in reducing pro-fibrotic changes in human corneal epithelial cells. Sci. Rep. 11, 4392. https:\/\/doi.org\/10.1038\/s41598-021-83881-y (2021).","journal-title":"Sci. Rep."},{"key":"83757_CR17","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3109\/08820538.2015.1088552","volume":"32","author":"JN Kruh","year":"2017","unstructured":"Kruh, J. N., Garrett, K. A., Huntington, B., Robinson, S. & Melki, S. A. Risk factors for Retreatment following myopic LASIK with Femtosecond laser and Custom Ablation for the treatment of myopia. Semin Ophthalmol. 32, 316\u2013320. https:\/\/doi.org\/10.3109\/08820538.2015.1088552 (2017).","journal-title":"Semin Ophthalmol."},{"key":"83757_CR18","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12886-018-0879-y","volume":"18","author":"M Naderi","year":"2018","unstructured":"Naderi, M., Sabour, S., Khodakarim, S. & Daneshgar, F. Studying the factors related to refractive error regression after PRK surgery. BMC Ophthalmol. 18, 198. https:\/\/doi.org\/10.1186\/s12886-018-0879-y (2018).","journal-title":"BMC Ophthalmol."},{"key":"83757_CR19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3928\/1081-597x-20010301-05","volume":"17","author":"KF Tabbara","year":"2001","unstructured":"Tabbara, K. F., El-Sheikh, H. F. & Islam, S. M. Laser in situ keratomileusis for the correction of hyperopia from +\u20090.50 to +\u200911.50 diopters with the Keracor 117\u00a0C laser. J. Refract. Surg. 17, 123\u2013128. https:\/\/doi.org\/10.3928\/1081-597x-20010301-05 (2001).","journal-title":"J. Refract. Surg."},{"key":"83757_CR20","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3928\/1081-597x-19970901-06","volume":"13","author":"J Pietil\u00e4","year":"1997","unstructured":"Pietil\u00e4, J., M\u00e4kinen, P., Pajari, S. & Uusitalo, H. Excimer laser photorefractive keratectomy for hyperopia. J. Refract. Surg. 13, 504\u2013510. https:\/\/doi.org\/10.3928\/1081-597x-19970901-06 (1997).","journal-title":"J. Refract. Surg."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83757-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83757-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83757-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T14:09:36Z","timestamp":1736172576000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83757-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,6]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["83757"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-83757-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,6]]},"assertion":[{"value":"16 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"961"}}